s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
DEF 14A
Definitive proxy statements
Filed
Monday, October 7, 2024
Period
Oct 7, 2024
Accession number
0001493152-24-040286
Documents
formdef14a.htm
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header